NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/15/2022
Back to search
Official data from USPTO
AKERO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
11/15/2022
Trademark type
Combined
Nice classes
5
Filing date
08/22/2018
Registration date
11/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/15/2022
Last transaction
11/15/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/15/2022
First use in commerce
2022-06-00
Drawing code
3
Owner type
03
Owner location
South San Francisco, CA
Examiner
LEE, JANET
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "AKERO", where the letters, "A", "K", "R", and, "O" are in lowercase letter and the letter "E" shown as three horizontal lines, where the middle bar is depicted as an arrow and a small circle is to the left of the arrow.
Holders and representatives
Holders
Akero Therapeutics, Inc.
Akero Therapeutics, Inc.
Representatives
Tiffany D. Gehrke Marshall, Gerstein & Borun LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationscompounds for use in the treatment of nonalcoholic steatohepatitis (NASH)fibrosisinflammatory and autoimmune disorderscirrhosismetabolic diseasescardiovascular diseasesliver fibrosiskidney fibrosislung fibrosis and/or heart fibrosisretinal and neurodegenerative and other related diseases and disorders; Pharmaceutical preparations for the treatment of fatty liver diseases and disorders and Steatohepatitis and other related diseases and disorders
Publications
History of USPTO decisions and trademark events.
58 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/15/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/13/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/12/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/30/2022
IUAF
USE AMENDMENT FILED
09/27/2022
EISU
TEAS STATEMENT OF USE RECEIVED
09/27/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/29/2022
EX5G
SOU EXTENSION 5 GRANTED
03/28/2022
EXT5
SOU EXTENSION 5 FILED
03/25/2022
EEXT
SOU TEAS EXTENSION RECEIVED
03/25/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/01/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/01/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/01/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/18/2021
EX4G
SOU EXTENSION 4 GRANTED
09/16/2021
EXT4
SOU EXTENSION 4 FILED
09/16/2021
EEXT
SOU TEAS EXTENSION RECEIVED
09/16/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/30/2021
EX3G
SOU EXTENSION 3 GRANTED
03/26/2021
EXT3
SOU EXTENSION 3 FILED
03/26/2021
EEXT
SOU TEAS EXTENSION RECEIVED
03/26/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/20/2020
NOAC
CORRECTED NOA E-MAILED
11/20/2020
EX2G
SOU EXTENSION 2 GRANTED
11/19/2020
DPCC
DIVISIONAL PROCESSING COMPLETE
11/19/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/19/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/05/2020
EXT2
SOU EXTENSION 2 FILED
09/28/2020
DRRR
DIVISIONAL REQUEST RECEIVED
09/28/2020
EEXT
SOU TEAS EXTENSION RECEIVED
09/28/2020
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
09/28/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/28/2020
EX1G
SOU EXTENSION 1 GRANTED
03/26/2020
EXT1
SOU EXTENSION 1 FILED
03/26/2020
EEXT
SOU TEAS EXTENSION RECEIVED
03/26/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/19/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/19/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/19/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/19/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/19/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/19/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/01/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2019
PUBO
PUBLISHED FOR OPPOSITION
08/06/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2019
ALIE
ASSIGNED TO LIE
07/02/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/10/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
12/13/2018
GPRA
PRIORITY ACTION E-MAILED
12/13/2018
CPRA
PRIORITY ACTION WRITTEN
12/13/2018
DOCK
ASSIGNED TO EXAMINER
12/07/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/31/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/30/2018
NWAP
NEW APPLICATION ENTERED
08/25/2018
Continuous trademark protection
Get notified about every new filing that threatens AKERO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.